Literature DB >> 10203334

Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury.

D O Okonkwo1, A Büki, R Siman, J T Povlishock.   

Abstract

In traumatic axonal injury, Ca2+ influx across a focally damaged axolemma precipitates local mitochondrial failure, degradation of the subaxolemmal spectrin network and compaction of neurofilaments, which collectively contribute to axonal failure. In previous studies, cyclosporin A pretreatment preserved mitochondrial integrity and attenuated axonal failure following trauma. Here we investigate whether this CsA-linked protection was related to the concomitant blunting of intra-axonal, Ca2+-induced cytoskeletal changes in traumatic axonal injury, assessed with antibodies targeting spectrin proteolysis and neurofilament compaction. CsA pretreatment dramatically reduced Ca2+-induced cytoskeletal damage following injury; CsA-treated rats, compared with vehicle-treated rats, displayed a 70% decrease in immunoreactive/damaged profiles. We suggest that CsA-mediated preservation of mitochondrial integrity enables the restoration of ionic and metabolic homeostasis thereby short-circuiting Ca2+-induced proteolysis in injured axons.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203334     DOI: 10.1097/00001756-199902050-00026

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  47 in total

Review 1.  Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies.

Authors:  David J Loane; Alan I Faden
Journal:  Trends Pharmacol Sci       Date:  2010-10-29       Impact factor: 14.819

2.  Unmyelinated axons show selective rostrocaudal pathology in the corpus callosum after traumatic brain injury.

Authors:  Thomas M Reeves; Terry L Smith; Judy C Williamson; Linda L Phillips
Journal:  J Neuropathol Exp Neurol       Date:  2012-03       Impact factor: 3.685

Review 3.  The mitochondrial permeability transition in neurologic disease.

Authors:  M D Norenberg; K V Rama Rao
Journal:  Neurochem Int       Date:  2007-03-04       Impact factor: 3.921

Review 4.  Multifunctional drugs for head injury.

Authors:  Robert Vink; Alan J Nimmo
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

Review 5.  Traumatic brain injury: can the consequences be stopped?

Authors:  Eugene Park; Joshua D Bell; Andrew J Baker
Journal:  CMAJ       Date:  2008-04-22       Impact factor: 8.262

6.  A novel strategy to activate cytoprotective genes in the injured brain.

Authors:  Jing Zhao; John B Redell; Anthony N Moore; Pramod K Dash
Journal:  Biochem Biophys Res Commun       Date:  2011-03-22       Impact factor: 3.575

7.  Role of cyclophilin D-dependent mitochondrial permeability transition in glutamate-induced calcium deregulation and excitotoxic neuronal death.

Authors:  Viacheslav Li; Tatiana Brustovetsky; Nickolay Brustovetsky
Journal:  Exp Neurol       Date:  2009-02-21       Impact factor: 5.330

8.  Differential effects of FK506 on structural and functional axonal deficits after diffuse brain injury in the immature rat.

Authors:  Ann Mae Dileonardi; Jimmy W Huh; Ramesh Raghupathi
Journal:  J Neuropathol Exp Neurol       Date:  2012-11       Impact factor: 3.685

9.  Therapy development for diffuse axonal injury.

Authors:  Douglas H Smith; Ramona Hicks; John T Povlishock
Journal:  J Neurotrauma       Date:  2013-02-14       Impact factor: 5.269

Review 10.  Posthypothermic rewarming considerations following traumatic brain injury.

Authors:  John T Povlishock; Enoch P Wei
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.